Kelly S. Da Costa
Sheffield, ENG S14DT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Phase 1 and preclinical studies reveal safety, pharmacokinetics, and efficacy of intranasal delivery of the influenza antibody CR9114.
Journal: Science translational medicine
Published: February 04, 2026
Investigating factors driving shifts in subtype dominance within H5Nx clade 2.3.4.4b high pathogenicity avian influenza viruses.
Journal: The Journal of general virology
Published: September 01, 2025
Development and Qualification of a Pseudotyped Virus-Based Microneutralisation Assay for Influenza D Virus.
Journal: Influenza and other respiratory viruses
Published: July 21, 2025
Development and optimisation of influenza C and influenza D pseudotyped viruses.
Journal: Journal of virological methods
Published: June 13, 2025
Expanded adaptive NKG2C+ NK cells exhibit potent ADCC and functional responses against HBV-infected hepatoma cell lines.
Journal: bioRxiv : the preprint server for biology
Published: June 12, 2025
Stem-like CD8+ T cells preserve HBV-specific responses in HBV/HIV co-infection.
Journal: medRxiv : the preprint server for health sciences
Published: April 16, 2025
Stem-like CD8+ T cells preserve HBV-specific responses in HBV/HIV co-infection.
Journal: Gut
Published: April 01, 2025
Intranasal administration of a panreactive influenza antibody reveals Fc-independent mode of protection.
Journal: Scientific reports
Published: August 26, 2024
Conference Report: LPMHealthcare Emerging Viruses 2023 (EVOX23): Pandemics-Learning from the Past and Present to Prepare for the Future.
Journal: Pathogens (Basel, Switzerland)
Published: July 29, 2024
Serological analysis in humans in Malaysian Borneo suggests prior exposure to H5 avian influenza near migratory shorebird habitats.
Journal: Nature communications
Published: March 06, 2024
Last Updated: 09/26/2026